Lebek S, Tafelmeier M, Messmann R, Provaznik Z, et al. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease. Eur J Heart Fail 2020;22:2248-2257.
PMID: 33017071